Unrelated Umbilical Cord Blood Unit Selection

Seminars in Hematology

Volumn 47, Issue 1, 2010, Pages 13-21

  Scaradavou, Andromachi ^a  

^a NEW YORK BLOOD CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN; HLA ANTIGEN CLASS 1; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR;

ARTICLE; BLOOD COMPATIBILITY; BLOOD CYTOLOGY; BLOOD STORAGE; CELL COUNT; CELL DENSITY; CORD BLOOD STEM CELL TRANSPLANTATION; DONOR SELECTION; ENGRAFTMENT; ERYTHROCYTE CONCENTRATE; GRAFT RECIPIENT; HEMATOLOGIC MALIGNANCY; HLA MATCHING; HLA SYSTEM; HUMAN; LEUKEMIA; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RECURRENCE RISK; UMBILICAL CORD BLOOD;

BLOOD DONORS; CELL COUNT; CORD BLOOD STEM CELL TRANSPLANTATION; HEMATOLOGIC DISEASES; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; NEW YORK CITY; PATIENT SELECTION; PEDIGREE; PRACTICE GUIDELINES AS TOPIC; PROGRAM DEVELOPMENT; RECURRENCE; TIME FACTORS; TREATMENT OUTCOME;

EID: 72449161244     PISSN: 00371963     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminhematol.2009.10.003     Document Type: Article

References (49)

1. World Marrow Donor Association 2008 annual report (2008), WMDA
2. Lee S.J., Klein J., Haagenson M., Baxter-Lowe L.A., Confer D.L., Eapen M., et al. High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation. Blood 110 (2007) 4576-4583
3. Gluckman E., Rocha V., Boyer-Chammard A., Locatelli F., Arcese W., Pasquini R., et al. Outcome of cord blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group. N Engl J Med 337 (1997) 373-381
4. Rubinstein P., Carrier C., Scaradavou A., Kurtzberg J., Adamson J., Migliaccio A.R., et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med 339 (1998) 1565-1577
5. Rocha V., and Locatelli F. Searching for alternative hematopoietic stem cell donors for pediatric patients. Bone Marrow Transplant 41 (2008) 207-714
6. Kamani N., Spellman S., Hurley C.K., Barker J.N., Smith F.O., Oudshoorn M., et al. State of the art review: HLA matching and outcome of unrelated donor umbilical cord blood transplants. Biol Blood Marrow Transplant 14 (2008) 1-6
7. Gluckman E., and Rocha V. Cord blood transplantation: state of the art. Hematologica 94 (2009) 451-454
8. Wall D.A., and Chan K.W. Selection of cod blood unit(s) for transplantation. Bone Marrow Transplant 42 (2008) 1-7
9. Wagner J.E., Barker J.N., DeFor T.E., Baker K.S., Blazar B.R., Eide C., et al. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood 100 (2002) 1611-1618
10. Rocha V., Wagner J.E., Sobocinski K.A., Klein J.P., Zhang M.-J., Horowitz M.M., et al. Graft-versus-host disease in children who have received a cord blood or bone marrow transplant from an HLA-identical sibling. N Engl J Med 342 (2000) 1846-1854
11. Laughlin M.J., Barker J., Bambach B., Koc O.N., Rizzieri D.A., Wagner J.E., et al. Hematopoietic engraftment and survival in adult recipients of umbilical cord blood from unrelated donors. N Engl J Med 344 (2001) 1815-1822
12. Laughlin M.J., Eapen M., Rubinstein P., Wagner J.E., Zhang M.J., Champlin R.E., et al. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. N Engl J Med 351 (2004) 2265-2275
13. Rocha V., Labopin M., Sanz G., Arcese W., Schwerdtfeger R., Bosi A., et al., Acute Leukemia Working Party of European Blood and Marrow Transplant Group and the Eurocord-Netcord Registry. Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. N Engl J Med 351 (2004) 2276-2285
14. Eapen M., Rubinstein P., Zhang M.-J., Stevens C., Kurtzberg J., Scaradavou A., et al. Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukemia: a comparison study. Lancet 369 (2007) 1947-1954
15. Gibbons R. Analysis of the NYBC, NMDP and NHLBI cord blood data, IOM report. Cord blood: establishing a national hematopoietic stem cell bank program (2005), Institute of Medicine 265-273
16. Scaradavou A., Stevens C., Dobrila L., Zhu T., Jiang S., Daniels D., et al. Cord blood unit mononuclear cell (MNC) dose: effect on transplantation outcome and relevance to processing method and CBU selection [abstract]. ASH Annual Meeting Abstracts 112 (2008) 1969
17. Migliaccio A.R., Adamson J.W., Stevens C.E., Dobrila N.L., Carrier C.M., and Rubinstein P. Cell dose and speed of engraftment in placental/umbilical cord blood transplantation: graft progenitor cell content is a better predictor than nucleated cell quantity. Blood 96 (2000) 2717-2722
18. Prasad V.K., Mendizabal A., Parikh S.H., Szabolcs P., Driscoll T.A., Page K., et al. Unrelated donor umbilical cord blood transplantation for inherited metabolic disorders in 159 pediatric patients from a single center: influence of cellular composition of the graft on transplantation outcomes. Blood 112 (2008) 2979-2989
19. Page K.M., Mendizabal A., Waters-Pick B., Avrutsky S., Reese M., Prasad V., et al. Post thaw colony forming units (CFU) is a strong independent predictor of engraftment after unrelated umbilical cord blood transplantation (UCBT) [abstract]. ASH Annual Meeting Abstracts 110 (2007) 3282
20. Wagner E., Duval M., Dalle J.-H., Morin H., Bizier S., Champagne J., et al. Assessment of cord blood unit characteristics on the day of transplant: comparison with data issued by cord blood banks. Transfusion 46 (2006) 1190-1198
21. Kurtzberg J., Balber A., Mendizabal A., Reese M., Kaestner A., Gentry T., et al. Preliminary results of a pilot trial of unrelated umbilical cord blood transplantation (UCBT) augmented with cytokine-primed aldehyde dehydrogenase-bright (ALDHbr) cells [abstract]. ASH Annual Meeting Abstracts 108 (2006) 3641
22. Barker J.N., Scaradavou A., Stevens C., and Rubinstein P. The dose-match interaction in umbilical cord blood (UCB) transplantation: an analysis of the impact of cell dose and HLA-match on the disease-free survival (DFS) of 989 patients transplanted with single units for hematologic malignancy [abstract]. ASH Annual Meeting Abstracts 110 (2007) 105
23. Barker J.N., Scaradavou A., Stevens C., and Rubinstein P. The dose-match interaction in umbilical cord blood (UCB) transplantation: an analysis of the impact of cell dose and HLA-match on the disease-free survival (DFS) of 989 patients transplanted with single units for hematologic malignancy [abstract] (June 2008), Sixth Annual International UCB Symposium, Los Angeles
24. Rubinstein P., Stevens C.E., Scaradavou A., Carrier C., and Carpenter C. HLA in cord blood transplantation: role of homozygosity in engraftment, GvHD, relapse and survival [abstract]. ASH Annual Meeting Abstracts 102 (2003) 478
25. Ottinger H.D., Ferencik S., Beelen D.W., Lindemann M., Peceny R., Elmaagacli A.H., et al. Hematopoietic stem cell transplantation: contrasting the outcome of transplantations from HLA-identical siblings, partially HLA-mismatched related donors, and HLA matched unrelated donors. Blood 102 (2003) 1131-1137
26. Matsuno N., Wake A., Uchida N., Ishiwata K., Aroaka H., Takagi S., et al. Impact of HLA disparity in the graft-versus-host direction on engraftment in adult patients receiving reduced-intensity cord blood transplantation. Blood 114 (2009) 1689-1695
27. Stevens C.E., Rubinstein P., and Scaradavou A. HLA matching in cord blood transplantation: clinical outcome and implications for cord blood unit selection and inventory size and ethnic composition [abstract]. ASH Annual Meeting Abstracts 108 (2006) 3104
28. van Rood J.J., Roelen D.L., and Claas F.H. The effect of noninherited maternal antigens in allogeneic transplantation. Semin Hematol 42 (2005) 104-111
29. van Rood J.J., and Oudshoorn M. When selecting a HLA mismatched stem cell donor consider donor immune status. Curr Opinion Immunol 21 (2009) 1-6
30. van Rood JJ, Stevens CE, Schmits J, Carrier C, Carpenter C, Scaradavou A. Re-exposure of cord blood to non-inherited maternal HLA antigens improves transplant outcome in hematological malignancies and might enhance its anti-leukemic effect. Proc Natl Acad Sci U S A. Epub ahead of print doi 10.1073/pnas.0910310106.
31. Kogler G., Enszmann J., Rocha V., Gluckman E., and Wernet P. High-resolution HLA typing by sequencing for HLA-A, -B, -C, -DR, -DQ in 122 unrelated cord blood/patient pair transplants hardly improves long-term clinical outcome. Bone Marrow Transplant 36 (2005) 1033-1041
32. Kurtzberg J., Prasad V.K., Carter S.L., Wagner J.E., Baxter-Lowe L.A., Wall D., et al. Results of the Cord Blood Transplantation Study (COBLT): clinical outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with hematologic malignancies. Blood 112 (2008) 4318-4327
33. Eapen M., Klein J., Sanz G., Anasetti C., Garcia J., Gluckman E., et al. Donor-recipient matching at the HLA-C locus and early outcomes after unrelated umbilical cord blood transplant (UCBT) [abstract]. ASH Annual Meeting Abstracts 112 (2008) 153
34. Willemze R., Rodrigues C.A., Labopin M., Sanz G., Michel G., Socie G., et al. KIR-ligand incompatibility in the graft-versus-host direction improves outcomes after umbilical cord blood transplantation for acute leukemia. Leukemia 23 (2009) 492-500
35. Brunstein C.G., Wagner J.E., Weisdorf D.J., Cooley S., Noreen H., Barker J.N., et al. Negative effect of KIR alloreactivity in recipients of umbilical cord blood transplant depends on transplantation conditioning intensity. Blood 113 (2009) 5628-5634
36. Barker J.N., Weisdorf D.J., DeFor T.E., Blazar B.R., McGrave P.B., et al. Transplantation of two partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy. Blood 105 (2005) 1343-1347
37. Brunstein C.G., Barker J.N., Weisdorf D.J., DeFor T.E., Miller J.S., Blazar B.R., et al. Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease. Blood 110 (2007) 3064-3070
38. Barker J.N., Abboud M., Rice R.D., Hawke R., Schaible A., Heller G., et al. A "no-wash" albumin-dextran dilution strategy for cord blood unit thaw: high rate of engraftment and a low incidence of serious infection reactions. Biol Blood Marrow Transplant (2009) Epub ahead of print. DOI 10.1016/jbbmt.2009.08.009
39. Rocha V., and Gluckman E. Improving outcomes of cord blood transplantation: HLA matching, cell dose and other graft- and transplantation-related factors. Br J Haematol 147 (2009) 262-274
40. Grewal S.S., Barker J.N., Davies S.M., and Wagner J.E. Unrelated donor hematopoietic cell transplantation: marrow or umbilical cord blood?. Blood 101 (2003) 4233-4244
41. Gluckman E., Rocha V., Arcese W., Michel G., Sanz G., Chan K.W., et al. Factors associated with outcomes of unrelated cord blood transplant: guidelines for donor choice. Exp Hematol 32 (2004) 397-407
42. Rio B., Furst S., Renaud M., Legrand F., Tabrizi R., Uzunov M., et al. Encouraging results of unrelated cord blood transplantation (UCBT) after homogenous reduced intensity conditioning (RIC) in adults with hematological malignancies: impact of HLA disparities on outcomes. A French multicentre study on behalf of the SFGM-TC and Eurocord [abstract]. Bone Marrow Transplant 43 Suppl 1 (2009) 107
43. Guidance for industry. potency tests for cellular and gene therapy products. (Draft Guidance) (October 2008), US Food and Drug Administration, Washington, DC
44. Rodriguez L., Garcia J., and Querol S. Predictive utility of the attached segment in the quality control of a cord blood graft. Biol Blood Marrow Transplant 11 (2005) 247-251
45. Albano M.S., Stevens C.E., Dobrila L., Scaradavou A., and Rubinstein P. Colony-forming-unit (CFU) assay with high-resolution digital imaging: a reliable system for cord blood (CB) CFU evaluation [abstract] (February 2009), ASBMT Annual Meeting Abstracts, Tampa, FL
46. McCullough J., McKenna D., Kadidlo D., Maurer D., Noreen H.J., French K., et al. Mislabeled units of umbilical cord blood detected by a quality assurance program at the transplantation center. Blood 114 (2009) 1684-1688
47. Broxmeyer H.E., Srour E.F., Hangoc G., Cooper S., Anderson S.A., and Bodine D.M. High-efficiency recovery of functional hematopoietic progenitor and stem cells from human cord blood cryopreserved for 15 years. Proc Natl Acad Sci U S A 100 (2003) 645-650
48. Scaradavou A., Stevens C.E., Dobrila L., Sung D., and Rubinstein P. "Age" of the cord blood (CB) unit: impact of long-term cryopreservation and storage on transplant outcome [abstract]. ASH Annual Meeting Abstracts 110 (2007) 2033
49. Chow R., Nademanee A., Rosenthal J., Karanes C., Jaing T.-H., Graham M., et al. Analysis of hematopoietic cell transplants using plasma-depleted cord blood products that are not red cell reduced. Biol Blood Marrow Transplant 13 (2007) 1346-1357